Ordering
Available Variants0.1 mg
CHA.43203-0.1mg
Price
€380.80
Available – Dispatch in 14 days
500 μg
CHA.43203-500μg
Price
€711.20
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
0.1 mg | CHA.43203-0.1mg | €380.80 |
|
Available – Dispatch in 14 days
Global Network - International delivery
|
500 μg | CHA.43203-500μg | €711.20 |
≥97%
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C184H282N50O60S |
|---|---|
| CAS Number | 141758-74-9 |
| Molecular Weight | 4186.57 |
| UNSPSC Code | 51111800 |
| NACRES | NA.32 |
| MDL number | MFCD00240171 |
Safety Information Handling visibility
| Storage Class | 11 - Combustible Solids |
|---|---|
| wgk | WGK 3 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
| ppe | Eyeshields, Gloves, type N95 (US) |
Technical Overview & Applications Use-case context
Exendin-4, also known as exenatide, is a synthetic version of the naturally occurring peptide exendin-4, with a CAS number of 141758-74-9. It is a glucagon-like peptide-1 receptor agonist, which plays a crucial role in glucose metabolism and insulin secretion. Exendin-4 has been shown to enhance glucose-dependent insulin secretion, suppress inappropriately elevated glucagon secretion, and slow gastric emptying. As a result, it has been used in the treatment of type 2 diabetes mellitus, exhibiting improved glycemic control and potential benefits for weight management and cardiovascular risk factors. The peptides mechanism of action involves binding to specific receptors in the pancreas, leading to increased insulin release and decreased glucagon levels, thereby regulating blood glucose levels and improving overall metabolic function. Its therapeutic potential has been extensively studied and validated in various clinical trials.
